Molecular mechanisms of diabetic heart disease: Insights from transcriptomic technologies

Marcella Conning-Rowland1, Richard M Cubbon1

  • 1Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK.

PubMed

Insights

Diabetes mellitus (DM) significantly increases heart failure risk. This review highlights altered fatty acid metabolism and inflammation in the heart as key factors, suggesting new therapeutic targets for diabetic heart disease.

Area of Science:

  • Cardiovascular Research
  • Metabolic Disease
  • Molecular Biology

Background:

  • Diabetes mellitus (DM) affects over 500 million adults globally.
  • DM doubles the risk of major cardiovascular events and specifically elevates heart failure risk, independent of other conditions.
  • Endothelial cell (EC) dysfunction, a hallmark of DM, contributes to cardiac complications.

Purpose of the Study:

  • To systematically review 'omics' studies identifying molecular drivers of cardiac dysfunction in DM.
  • To elucidate the extent to which EC dysfunction and other factors contribute to DM-associated heart failure.
  • To identify novel therapeutic targets for diabetic heart disease.

Main Methods:

  • Systematic review of transcriptomics studies on the myocardium and cardiac ECs in DM.
  • Analysis of 'omics' data to identify common molecular themes.
  • Synthesis of findings to pinpoint key pathological processes.

Main Results:

  • Common themes identified include significant alterations in myocardial fatty acid metabolism.
  • Increased inflammation within the myocardium is a recurring finding in DM.
  • These molecular changes are linked to myocardial dysfunction and heart failure.

Conclusions:

  • Altered fatty acid metabolism and inflammation are key molecular processes underlying heart failure in diabetes mellitus.
  • Further research is needed to validate these factors as causal and prioritize them for therapeutic development.
  • Targeting these pathways may offer novel treatment strategies for diabetic cardiomyopathy.

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...